Subscribe: Market Wire - Medical and Healthcare: Alternative
Added By: Feedage Forager Feedage Grade B rated
Language: English
bio pharma  bio  cannabinoid oil  marketwired  nept  neptune  oil based  otcqb tbpmf  pharma  products  purified cannabinoid  tetra bio  tetra  tsx 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Alternative

Marketwired - Alternative

Marketwired - Alternative

Last Build Date: Thu, 15 Feb 2018 09:01:25 EST

Copyright: Copyright: (C) Marketwired

Solis Tek Announces Appointment of Co-Founder Alan Lien as Chief Executive Officer

Thu, 15 Feb 2018 08:30:00 EST

CARSON, CA--(Marketwired - February 15, 2018) - Solis Tek Inc. (OTCQB: SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today announced that its Co-Founder, Chairman, Chief Financial Officer and President, Alan Lien, has been appointed Chief Executive Officer. Mr. Lien replaces Dennis G. Forchic, who has been removed both from his role as CEO and as a member of the Board of Directors due to a difference in strategic outlook that was incompatible with the majority of the Founding Directors' plans and expectations for the Company.

Neptune annonce ses résultats pour le troisième trimestre

Wed, 14 Feb 2018 16:30:22 EST

Les activités du secteur du cannabis progressent comme prévu

Neptune Announces Third Quarter Results

Wed, 14 Feb 2018 16:00:00 EST

Cannabis Business Development Underway and On Schedule

Neptune et Tetra Bio-Pharma concluent une entente de codéveloppement de produits antidouleurs et anti-inflammatoires à base d'huiles de cannabinoïdes purifiés

Mon, 12 Feb 2018 12:43:09 EST

LAVAL, QUÉBEC--(Marketwired - 12 fév. 2018) - Neptune Technologies & Bioressources inc. (« Neptune ») (NASDAQ:NEPT)(TSX:NEPT) et Tetra Bio-Pharma Inc. (« Tetra ») (TSX CROISSANCE:TBP)(OTCQB:TBPMF) ont annoncé aujourd'hui la conclusion d'une entente de codéveloppement, de commercialisation et de mise en marché de produits à base d'huiles de cannabinoïdes purifiés contre la douleur et l'inflammation à l'intention des marchés des produits de santé naturelle et de la médecine vétérinaire.

Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation

Mon, 12 Feb 2018 08:00:00 EST

LAVAL, QUÉBEC--(Marketwired - Feb. 12, 2018) - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ:NEPT)(TSX:NEPT) and Tetra Bio-Pharma Inc. ("Tetra") (TSX VENTURE:TBP)(OTCQB:TBPMF) today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.